Performing native mass spectrometry analysis on therapeutic antibodies. (Q50978761)

26 March 2018

title

Performing native mass spectrometry analysis on therapeutic antibodies. (English)

1 reference

26 March 2018

1 reference

3

1 reference

26 March 2018

author name string

Natalie J Thompson

series ordinal

1

1 reference

26 March 2018

Sara Rosati

series ordinal

2

1 reference

26 March 2018

publication date

18 May 2013

1 reference

26 March 2018

published in

Methods

1 reference

26 March 2018

volume

65

1 reference

26 March 2018

issue

1

1 reference

26 March 2018

page(s)

11-17

1 reference

26 March 2018

Matrix-assisted ultraviolet laser desorption of non-volatile compounds

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.05.003

Electrospray ionization for mass spectrometry of large biomolecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.05.003

Native mass spectrometry: a bridge between interactomics and structural biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.05.003

Native protein mass spectrometry: from intact oligomers to functional machineries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.05.003

The role of mass spectrometry in structure elucidation of dynamic protein complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.05.003

Modern biomolecular mass spectrometry and its role in studying virus structure, dynamics, and assembly.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.05.003

Antibody therapy of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.05.003

Tau-targeted treatment strategies in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.05.003

Pharmacokinetic considerations for antibody drug conjugates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.05.003

Therapeutic antibodies: successes, limitations and hopes for the future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.05.003

Recombinant protein therapeutics--success rates, market trends and values to 2010.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.05.003

Strategies and challenges for the next generation of therapeutic antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.05.003

7 January 2021

IgG4 breaking the rules

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.05.003

Quantitative Analysis of the Interaction Strength and Dynamics of Human IgG4 Half Molecules by Native Mass Spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.05.003

Advances and challenges in analytical characterization of biotechnology products: mass spectrometry-based approaches to study properties and behavior of protein therapeutics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.05.003

Mass spectrometry for structural characterization of therapeutic antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.05.003

Characterization of therapeutic antibodies and related products.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.05.003

Applications of mass spectrometry for the structural characterization of recombinant protein pharmaceuticals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.05.003

The impact of mass spectrometry on the study of intact antibodies: from post-translational modifications to structural analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.05.003

Electrospray: from ions in solution to ions in the gas phase, what we know now.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.05.003

Electrospray ionization of large multiply charged species proceeds via Dole’s charged residue mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.05.003

Analytical properties of the nanoelectrospray ion source

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.05.003

Qualitative and semiquantitative analysis of composite mixtures of antibodies by native mass spectrometry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.05.003

Extending mass spectrometry contribution to therapeutic monoclonal antibody lead optimization: characterization of immune complexes using noncovalent ESI-MS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.05.003

The effect of the source pressure on the abundance of ions of noncovalent protein assemblies in an electrospray ionization orthogonal time-of-flight instrument

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.05.003

Influence of pressure in the first pumping stage on analyte desolvation and fragmentation in nano-ESI MS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.05.003

Collisional cooling of large ions in electrospray mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.05.003

Improving the Performance of a Quadrupole Time-of-Flight Instrument for Macromolecular Mass Spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.05.003

A tandem mass spectrometer for improved transmission and analysis of large macromolecular assemblies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.05.003

Optimizing macromolecular tandem mass spectrometry of large non-covalent complexes using heavy collision gases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.05.003

Ion mobility mass spectrometry of proteins and protein assemblies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.05.003

Collision cross sections of proteins and their complexes: a calibration framework and database for gas-phase structural biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.05.003

Mass spectrometry of stanozolol and its analogues using electrospray ionization and collision-induced dissociation with quadrupole-linear ion trap and linear ion trap-orbitrap hybrid mass analyzers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.05.003

High-sensitivity Orbitrap mass analysis of intact macromolecular assemblies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.05.003

Exploring an Orbitrap Analyzer for the Characterization of Intact Antibodies by Native Mass Spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.05.003

Post-translational modifications differentially affect IgG1 conformation and receptor binding.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.05.003

Mutation of Y407 in the CH3 domain dramatically alters glycosylation and structure of human IgG

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.05.003

Effective use of mass spectrometry for glycan and glycopeptide structural analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.05.003

A systematic approach to protein glycosylation analysis: a path through the maze

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.05.003

Structural analysis of N- and O-glycans released from glycoproteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.05.003

Trends in glycosylation, glycoanalysis and glycoengineering of therapeutic antibodies and Fc-fusion proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.05.003

Analytical methods for physicochemical characterization of antibody drug conjugates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.05.003

Native intact mass determination of antibodies conjugated with monomethyl Auristatin E and F at interchain cysteine residues.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.05.003

Characterization and comparison of disulfide linkages and scrambling patterns in therapeutic monoclonal antibodies: using LC-MS with electron transfer dissociation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.05.003

Resolving disulfide structural isoforms of IgG2 monoclonal antibodies by ion mobility mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.05.003

Antibody cocktails: next-generation biopharmaceuticals with improved potency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.05.003

Conformation and dynamics of biopharmaceuticals: transition of mass spectrometry-based tools from academe to industry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.05.003

Discrimination among IgG1-kappa monoclonal antibodies produced by two cell lines using charge state distributions in nanoESI-TOF mass spectra

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.05.003

Species-Specific Determinants in the IgG CH3 Domain Enable Fab-Arm Exchange by Affecting the Noncovalent CH3-CH3 Interaction Strength

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.05.003

Therapeutic IgG4 antibodies engage in Fab-arm exchange with endogenous human IgG4 in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.05.003

Probing molecular interactions in intact antibody: antigen complexes, an electrospray time-of-flight mass spectrometry approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.05.003

Effects of antibody affinity and antigen valence on molecular forms of immune complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.05.003

Regional and segmental flexibility of antibodies in interaction with antigens of different size.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.05.003

In vitro stoichiometry of complexes between the soluble RANK ligand and the monoclonal antibody denosumab.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2013.05.003

10.1016/J.YMETH.2013.05.003

7 January 2021

Identifiers

DOI

1 reference

26 March 2018

1 reference

26 March 2018